ZUR ROSE GROUP AG

ROSE

Real-time Estimate - 06/29 06:08:53 am
73.65CHF	-5.27%

Turn to zoom

Prev.	77.7500
Open	77.0000
High	77.3000
Low	72.7000
Volume	92 139

6d ago	Zur Rose : Tobias Leipold, CEO and Co-Founder, leaves eHealth-Tec GmbH
6d ago	ZUR ROSE GROUP : Credit Suisse reaffirms its Sell rating
06/17	Zur Rose : Tobias Leipold, CEO and Co-Founder, leaves eHealth-Tec GmbH
06/08	ZUR ROSE GROUP : Gets a Sell rating from UBS

	Short Term	Mid-Term	Long Term
Trend	Bearish	Bearish	Bearish
Resistance	96,3	127	183
Spread/Res.	-19%	-39%	-58%
Spread/Supp.	7,3%	44%	35%
Support	72,5	53,9	57,5

Sales 2022	1 772 M 1 851 M 1 851 M
Net income 2022	-166 M -174 M -174 M
Net Debt 2022	437 M 457 M 457 M
P/E ratio 2022	-4,80x
Yield 2022	-

Capitalization	810 M 846 M 846 M
EV / Sales 2022	0,70x
EV / Sales 2023	0,60x
Nbr of Employees	2 131
Free-Float	85,3%

Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose...

Sector :

Other Drug Retailers

Calendar :

2022-08-18 Earnings Release

Trading Rating :

Investor Rating :

Sell Buy
Mean consensus	OUTPERFORM
Number of Analysts	13
Last Close Price	77,75 CHF
Average target price	166,50 CHF
Spread / Average Target	114%